LOADING
Comparing Thermo Fisher Scientific (TMO) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TMO | T |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $194.9B | $181.2B |
| P/E Ratio | 29.6 | 8.6 |
| Forward P/E | 21.2 | 11.4 |
| PEG Ratio | 1.95 | 1.48 |
| EPS | $17.73 | $3.00 |
| Revenue Growth (YoY) | 7.2% | 3.6% |
| Profit Margin | 15.0% | 17.5% |
| Return on Equity | 13.0% | 18.8% |
| Dividend Yield | 0.33% | 4.24% |
| Beta | 0.97 | 0.54 |
| 52-Week High | $643.35 | $29.14 |
| 52-Week Low | $384.44 | $22.71 |
| Volume | -- | -- |
Thermo Fisher Scientific is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AT&T Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.